Analyst: Biden attack on pharmaceutical industry seems symbolic

According to Søren Løntoft Hansen, senior analyst at Sydbank, the administration's new criticisms of medicine prices seem like a symbolic exercise.


Friday's order issued by US President Joe Biden seems more symbolic than a real challenge to prescription medicine prices, says Sydbank Senior Analyst Søren Løntoft Hansen.

In the order, Biden calls for action to decrease US medicine prices and increase competition, including importing medicine from Canada, increased support for generic drugs, a comprehensive plan for fighting high prices and, not least, a ban of the 'pay to delay' tactic, were large concerns have paid competitors not to enter the market.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

CHMP to remove 100 generic medicines from market

Due to fraudulent clinical trials from a contract research organization, the EMA’s expert committee, the CHMP, is now suspending marketing approval authorizations for around 100 generic drugs on the market.

Further reading

Related articles

Latest news

See all jobs